Sahlgrenska Universitetssjukhuset Östra
- Address
- Rondvägen 10, 41685 Gothenburg, Sweden
Sahlgrenska Universitetssjukhuset Östra - Pediatric Oncology Research
Sahlgrenska Universitetssjukhuset Östra is actively engaged in advancing treatments for childhood cancers, with particular expertise in pediatric hematologic malignancies. The center participates in innovative clinical research aimed at improving outcomes for children facing high-risk relapsed cancers through novel therapeutic approaches.
- Acute Lymphoblastic Leukemia (ALL) in pediatric populations
- High-risk relapsed B-cell precursor leukemia treatment strategies
- Targeted immunotherapy with novel agents like Inotuzumab Ozogamicin
The research center focuses on CD22-positive B-cell precursor acute lymphoblastic leukemia, conducting Phase 2 superiority studies that compare innovative monotherapy approaches with standard induction protocols. Their work specifically targets children aged 1 to 18 years with high-risk first bone marrow relapse, representing a critical area of unmet medical need in pediatric oncology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Pfizer Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sahlgrenska Universitetssjukhuset Östra
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study | Region Stockholm – SLSO | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Crisantaspase | 1 | Unknown | 2023-05-13 | 2023-05-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.